Genomic Investigation of Unusual Responders
common.study.values.description
“Genomic Investigation of Unusual Responders”
Studies have shown that tumors from the same patient may respond very differently to the same therapeutic agents. This study aims to investigate the genetic basis of tumors that respond abnormally well or poorly to therapeutic agents in an effort to understand the fundamental genetic basis of this response. The present protocol seeks to retrospectively perform Exome, next-generation (DNA) sequencing and/or other molecular techniques on tumor samples to identify the genetic basis of a patient's exceptional response to chemotherapy.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
common.study.methods.no-methods
participant.views.study.view.additional
participant.views.study.view.scientific-title
Genomic Investigation of Unusual Responders
common.study.values.clinical-trial-id
NCT03740503
participant.views.study.view.id
dPNMna
